TOR Equity Snapshot

FRX Weekly Equity Report

Fennec Pharmaceuticals Inc.

Interactive chart JSON snapshot
Latest Close 12.40 CAD 12 Jun 2026
1W Return -2.5% latest completed week
4W Return -6.8% short-term follow-through
12W Return 22.9% quarterly tape
Trend Breadth 46.2% 24 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
Company Brief

What the company does

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex …

Snapshot

What the weekly tape is saying

FRX closed the latest completed week at 12.40 CAD. The 4-week return is -6.8% and the 12-week return is 22.9%. Trend Signal is active, Market Dynamics is 1.20. Setup signature: Balanced read with a 42/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 15.7%
Volume 0.3x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 32 Persistence of active Trend Signal over the last year and current streak.
Momentum 55 Blend of 4-week and 12-week follow-through.
Dynamics 100 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 31 Relative leadership and short-term RS change.
Volume 14 Participation compared with the 13-week volume baseline.
Risk Control 18 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
10.72 CAD
Vs Trend Line
15.7%
Fair Value
10.49 CAD
Vs Fair Value
18.2%
52W High
14.24 CAD
52W Low
7.59 CAD
Drawdown
-12.9%
Range Position
72.3%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -2.5%
4W -6.8%
12W 22.9%
26W 17.0%
52W 15.2%

Trend read

Active Streak
2 weeks
52W Active Weeks
24
52W Active Breadth
46.2%
Sector Scope
CA Healthcare
Sector Rank
33 of 46
Sector Percentile
28.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
1.20
4W MD Change
2846.1%
Relative Strength
-2.54
4W RS Change
-136.7%
Expectation
Negative
Probability
42.93%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
1.9K
13W Average
5.8K
52W Average
3.9K
Vs 13W
0.3x
Vs 52W
0.5x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
13.3%
52W Volatility
8.2%
Upside Weeks
26
Downside Weeks
26
Downside Breadth
50.0%
Avg Gain / Loss
6.2% / -5.0%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
TOR
Country
CA
Sector
Healthcare
Industry
Biotechnology
Currency
CAD
Market Cap
474.9M

Opportunity signals

  • Trend Signal is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Recent volatility is running well above the one-year baseline.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 12.40 CAD -2.5% 10.72 CAD 10.49 CAD 1.20 -2.54 1.9K On
5 Jun 2026 12.72 CAD -6.9% 10.68 CAD 10.49 CAD 1.34 1.23 3.2K On
29 May 2026 13.67 CAD -0.1% 10.64 CAD 10.48 CAD 1.00 7.24 7.4K Off
22 May 2026 13.69 CAD 2.9% 10.57 CAD 10.46 CAD 0.53 8.12 8.4K Off
15 May 2026 13.31 CAD 37.9% 10.54 CAD 10.44 CAD 0.04 6.91 12.6K Off
8 May 2026 9.65 CAD 8.8% 10.48 CAD 10.42 CAD -0.45 -22.93 2.0K Off
1 May 2026 8.87 CAD -5.1% 10.57 CAD 10.42 CAD -0.53 -29.04 12.5K Off
24 Apr 2026 9.35 CAD -0.5% 10.73 CAD 10.43 CAD -0.66 -25.54 5.5K Off
17 Apr 2026 9.40 CAD 16.0% 10.84 CAD 10.44 CAD -0.67 -26.15 4.1K Off
10 Apr 2026 8.10 CAD -9.3% 10.93 CAD 10.45 CAD -0.61 -35.20 6.1K Off
3 Apr 2026 8.93 CAD 7.2% 11.08 CAD 10.47 CAD -0.39 -27.51 1.0K Off
27 Mar 2026 8.33 CAD -17.4% 11.20 CAD 10.49 CAD -0.19 -30.14 10.0K Off
20 Mar 2026 10.09 CAD -5.9% 11.33 CAD 10.50 CAD 0.10 -14.13 500 Off
13 Mar 2026 10.72 CAD 3.6% 11.39 CAD 10.51 CAD 0.46 -12.48 900 Off